Synthesized Magnolol Derivatives Improve Anti‐Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo

41Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Micropterus salmoides rhabdovirus (MSRV) is a primary viral pathogen in largemouth bass aquaculture, which leads to tremendous economic losses yearly. Currently, there are no approved drugs for the treatment and control of this virus. Our previous studies screened the herb Magnolia officinalis from many traditional Chinese medicines, and we isolated and identified magnolol as its main active compound against multiple rhabdoviruses, including MSRV. On the basis of the struc-ture–activity relationship and pharmacophore model of magnolol, two new magnolol derivatives, namely, hydrogenated magnolol and 2,2′‐dimethoxy‐magnolol, were designed and synthesized. Their anti‐MSRV activities were systematically investigated both in vitro and in vivo. By comparing the half‐maximal inhibitory concentration (IC50), it was found that hydrogenated magnolol pos-sessed a higher anti‐MSRV activity than magnolol and 2,2′‐dimethoxy‐magnolol, with an IC50 of 13.37 μM. Furthermore, hydrogenated magnolol exhibited a protective effect on the grass carp ovary (GCO) cell line by reducing the cytopathic effect induced by MSRV. Further studies revealed that hydrogenated magnolol did not directly impact virions or interfere with MSRV adsorption. It worked within the 6–8 h of the phase of virus replication. In vivo treatment of MSRV infection with magnolol and hydrogenated magnolol showed that they significantly improved the survival rate by 44.6% and 62.7%, respectively, compared to MSRV‐infected groups. The viral load measured by the expression of viral glycoprotein in the organs including the liver, spleen, and kidney also significantly decreased when fish were intraperitoneally injected at a dose of 20 mg/kg. Altogether, the structural optimization of magnolol via hydrogenation of the propylene groups increased its anti‐ MSRV activity both in vitro and in vivo. These results may provide a valuable reference for anti‐ MSRV drug discovery and development in aquaculture.

Cite

CITATION STYLE

APA

Jin, Y., Yang, F., Zhang, G., Yu, Q., Wang, G., Ling, F., & Liu, T. (2022). Synthesized Magnolol Derivatives Improve Anti‐Micropterus salmoides Rhabdovirus (MSRV) Activity In Vivo. Viruses, 14(7). https://doi.org/10.3390/v14071421

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free